Fundz

Morph Immune reported raising $15 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEMay 17, 2023

Amount Raised

$15 Million

$15 Million sold, per SEC Form D (first sale May 5, 2023)

Round Type

Venture

West LafayetteHealthcare

Quick answer

MorphImmune Inc. raised $15 Million in a funding round, dated May 5, 2023. MorphImmune Inc. is based in West Lafayette, Indiana, United States.

How much did MorphImmune Inc. raise?
MorphImmune Inc. raised $15 Million in a funding round on May 5, 2023.
What does MorphImmune Inc. do?
MorphImmune is a preclinical biotechnology company focused on developing targeted oncology therapeutics.
Where is MorphImmune Inc. based and how big is it?
MorphImmune Inc. is based in West Lafayette, Indiana, United States.
Who are the decision-makers at MorphImmune Inc?
Fundz holds 1 contact at MorphImmune Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as MorphImmune Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at MorphImmune Inc., and when

A new round usually means MorphImmune Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MorphImmune Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MorphImmune Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MorphImmune Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MorphImmune Inc.

Location

1281 WIN HENTSCHEL BOULEVARD

West Lafayette, Indiana, United States

About

MorphImmune is a preclinical biotechnology company focused on developing targeted oncology therapeutics. The company's proprietary Targeted Effector platform selectively delivers payloads to diseased cells. The targeted approach reduces toxicity and increases efficacy of known effector molecules, ultimately improving outcomes for patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MorphImmune Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsIsaac B., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MorphImmune Inc.'s next move

See what Strategic adds

MorphImmune Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.